Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Stromedix raises $25mm in Series B for fibrosis programs

08 May 2008

Executive Summary

Stromedix (fibrotic disease therapeutics) has completed a $25mm Series B round led by New Leaf Venture Partners along with other new investors Bessemer Venture Partners and Red Abbey Venture Partners. Returning backers Atlas Venture and Frazier Healthcare Ventures also participated in the financing. New Leaf's Ron Hunt and Bessemer's Chris Gabrieli will join Stromedix's board.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By